NCT03728764View on ClinicalTrials.gov

Growth and Safety of a Two-stage Feeding System in Preterm Infants

NACompletedINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

October 10, 2018

Primary Completion Date

September 19, 2019

Study Completion Date

December 15, 2019

Conditions
Preterm Infant
Interventions
OTHER

Preterm infant formula

Preterm infants will receive Stage 1 investigative product as soon as possible after birth until when 1.8 kg of body weight is achieved. Preterm infants will receive stage 2 preterm formula from when 1.8 kg of body weight is achieved until 1 month after hospital discharge.

Trial Locations (4)

304 60

University Hospital in Pilsen, Pilsen

30-663

Children's University Hospital, Krakow

03659

University Hospital in Martin, Martin

941 52

Fakultná nemocnica s poliklinikou, Nové Zámky

All Listed Sponsors
lead

Société des Produits Nestlé (SPN)

INDUSTRY

NCT03728764 - Growth and Safety of a Two-stage Feeding System in Preterm Infants | Biotech Hunter | Biotech Hunter